HomeNewsPelago scores $58M to scale digital clinic for substance use administration

Pelago scores $58M to scale digital clinic for substance use administration

Digital substance use administration platform Pelago, previously Stop Genius, introduced it secured $58 million in Sequence C funding, bringing its complete elevate to $151 million.Β 

Present investor Atomico led the spherical with participation from different persevering with traders, together with Octopus Ventures, Y Combinator and Kinnevik AB. New traders GreyMatter Capital and Eight Roads additionally participated.Β 

Laura Connell, associate at Atomico, will be a part of the corporate’s board of administrators.Β 

WHAT IT DOESΒ 

Pelago, based in 2015, works with well being plans, employers and particular person members to supply adults and adolescents personalised digital substance use care, together with therapy for alcohol, tobacco and opioid use.Β 

Members connect with a physician-led care group and might obtain complicated situation administration, cognitive behavioral remedy, and academic content material. The corporate additionally supplies a hub for medication-assisted therapy and distant monitoring instruments, akin to breathalyzers and urinary take a look at kits, for at-home use.Β 

Pelago will use the funds to speed up its product roadmap, conduct medical analysis and develop its continuum of care.Β Β 

“This funding demonstrates robust investor confidence in our development trajectory and displays our dominance of the substance use administration area. That trajectory features a tenfold development in income and eligible lives coated since our Sequence B spherical two years in the past,” Dr. Yusuf Sherwani, Pelago’s CEO and cofounder, informed Our blogNews in an e-mail.Β 

See also  Hybrid care supplier Harbor Well being secures $95.5M and extra digital well being fundings

“This fundraise helps advance our mission to interrupt down boundaries to substance use care that works. I’m extremely grateful for the employers and payers that we’ve empowered to handle substance use head-on by delivering specialised therapy and evidence-based care to their members, supported by highly effective outcomes information and validated ROI.”Β 

MARKET SNAPSHOT

The vast majority of direct prices related to substance use problems within the U.S. are incurred primarily among the many working-age inhabitants, in accordance with analysis printed in JAMA Community. Employers and medical insurance payers could offset these excessive prices by contemplating prevention and therapy methods.Β Β 

The digital dependancy therapy firm rebranded from Stop Genius final yr, two years after it closed a $64 million Sequence B funding spherical. The corporate garnered $11 million in Sequence A funding in 2020.Β Β 

There have been a number of different startups with digital instruments for dependancy. Maybe most notable is Pear Therapeutics, which supplied a line of digital therapeutics for substance abuse however filed for chapter in April of final yr. Its belongings have been offered at public sale for $6.05 million a month later.

Bicycle Well being is one other firm within the area, providing digital opioid use dysfunction therapy.Β 

Bicycle introduced final yr it shaped a partnership with compassionate care supplier Wellpath to supply previously incarcerated people entry to buprenorphine month-to-month injections for opioid use dysfunction by way of the Federal Bureau of Prisons and residential reentry facilities.

See also  Healthcare executives are investing in digital well being tech with out seeing an ROI

Different firms embrace digital alcohol use dysfunction therapy firm Ria Well being, digital dependancy therapy platform Workit Well being and digital smoking-cessation firm Carrot.Β 

Source link

RELATED ARTICLES

Most Popular